Finance

Lists
Why is EDIT down ၃.၀၁%?
Dive Deeper
EDIT:NASDAQ
Editas Medicine Inc
၁.၇၇ US$
-၃.၀၁%
(-၀.၀၅၅) 1D
၁.၇၈ US$
+၀.၅၈% (+၀.၀၁၀)
After hours
Closed: နို ၁၈, GMT-၅ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EDIT...
Open
၁.၈၆ US$
High
၁.၉၄ US$
Low
၁.၇၆ US$
Mkt. cap
၂၇.၂၄ ကုဋေ
Avg. vol.
၂.၃၉ သန်း
Volume
၁.၉၉ သန်း
52-wk high
၃.၉၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၆၂ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၄၃ ကုဋေ
No. of employees
၈၇
Open
၁.၈၆ US$
High
၁.၉၄ US$
Low
၁.၇၆ US$
Mkt. cap
၂၇.၂၄ ကုဋေ
Avg. vol.
၂.၃၉ သန်း
Volume
၁.၉၉ သန်း
52-wk high
၃.၉၄ US$
52-wk low
၁.၆၆ US$
EPS
-၀.၆၂ US$
Beta
၂.၀၉
Shares outstanding
၁၅.၄၃ ကုဋေ
No. of employees
၈၇
News stories
From web sources and news partners
The Motley Fool
The Motley Fool
·
ပြီးခဲ့သည့် ၁ နာရီ
Stock Market Today, Nov. 18: S&P 500 Breaks Key Support as Fed Minutes Signal More Rate Hikes Ahead
FXStreet
FXStreet
·
ပြီးခဲ့သည့် ၁ နာရီ
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
BeInCrypto
BeInCrypto
·
ပြီးခဲ့သည့် ၂ နာရီ
S&P 500 Breaks Critical Support: Is a Bigger Stock Market Crash Coming?
Traders Union
Traders Union
·
ပြီးခဲ့သည့် ၁ နာရီ
Peter Tuchman: S&P 500 loses $2.5 trillion in market cap over five days
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc
CEO-
Employees၈၇
Foundedနို ၂၀၁၃
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 4 analysts giving stock ratings to EDIT in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for EDIT in the last 3 months.
Highest
Current ၁.၇၇ US$
၆.၀၀ US$ (+၂၃၈.၉၈%)
Average
၅.၀၀ US$ (+၁၈၂.၄၉%)
Lowest
၄.၀၀ US$ (+၁၂၅.၉၉%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
၅.၀၀ US$
+၁၈၂.၅%
11/10/2026
Luca Issi
RBC Capital
Hold
Maintained
၄.၀၀ US$
+၁၂၆%
11/09/2026
Yanan Zhu
Wells Fargo
Buy
Maintained
၆.၀၀ US$
+၂၃၉%
11/09/2026
Debjit Chattopadhyay
Guggenheim
Buy
Upgraded
၅.၀၀ US$
+၁၈၂.၅%
09/23/2026
Rick Bienkowski
Ladenburg Thalmann & Co.
Buy
Initiated
၆.၀၀ US$
+၂၃၉%
08/18/2026
Alec Stranahan
Bank of America Securities
Sell
Reiterated
-
-
08/07/2026
Phil Nadeau
TD Cowen
Buy
Maintained
-
-
08/05/2026
Boris Peaker
JonesTrading
Buy
Maintained
၈.၀၀ US$
+၃၅၂%
08/05/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
၁၅.၀၀ US$
+၇၄၇.၅%
05/27/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
၄.၀၀ US$
+၁၂၆%
05/05/2026
Soumit Roy
JonesTrading
Buy
Maintained
၈.၀၀ US$
+၃၅၂%
04/06/2026
Joon Lee
Truist Financial
Hold
Maintained
-
-
03/17/2026
Brian Cheng
J.P. Morgan
Sell
Maintained
-
-
03/13/2026
William Maughan
Clear Street
Buy
Maintained
၄.၆၀ US$
+၁၅၉.၉%
03/10/2026
Last report
၂၀၂၆ နို ၉
Fiscal period
Q3 2026
-၀.၁၅ US$ / -၀.၂၁ US$
+၂၇.၂၃%beat
Revenue / Est. (USD)
၁.၀၄ ကုဋေ / ၄.၄၆ သန်း
+၁၃၂.၄၂%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၂.၄၇ ကုဋေ
၂.၈၃ သန်း
၁.၁၉ ကုဋေ
၁.၀၄ ကုဋေ
Cost of goods sold
၂.၇၄ ကုဋေ
၁.၇၆ ကုဋေ
၂.၀၂ ကုဋေ
၂.၁၂ ကုဋေ
Cost of revenue
၂.၇၄ ကုဋေ
၁.၇၆ ကုဋေ
၂.၀၂ ကုဋေ
၂.၁၂ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၁.၁၄ ကုဋေ
၁.၀၂ ကုဋေ
၁.၁၆ ကုဋေ
၁.၃၅ ကုဋေ
Operating expense
၁.၁၄ ကုဋေ
၁.၀၂ ကုဋေ
၁.၁၆ ကုဋေ
၁.၃၅ ကုဋေ
Total operating expenses
၃.၈၈ ကုဋေ
၂.၇၈ ကုဋေ
၃.၁၈ ကုဋေ
၃.၄၆ ကုဋေ
Operating income
-၁.၄၀ ကုဋေ
-၂.၅၀ ကုဋေ
-၁.၉၉ ကုဋေ
-၂.၄၃ ကုဋေ
Other non operating income
၂.၁၈ သန်း
-၁.၁၃ သိန်း
၁.၇၀ သောင်း
-၁.၀၀ ထောင်
EBT including unusual items
-၅.၆၂ သန်း
-၂.၅၀ ကုဋေ
-၁.၈၂ ကုဋေ
-၂.၃၄ ကုဋေ
EBT excluding unusual items
-၉.၆၉ သန်း
-၂.၅၀ ကုဋေ
-၁.၉၆ ကုဋေ
-၂.၃၄ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၅.၆၂ သန်း
-၂.၅၀ ကုဋေ
-၁.၈၂ ကုဋေ
-၂.၃၄ ကုဋေ
Net profit margin
-၂၂.၇၂%
-၈၈၂.၄၄%
-၁၅၃.၃၂%
-၂၂၅.၆၉%
Earnings per share
-၀.၀၆
-၀.၂၆
-၀.၁၅
-၀.၁၅
Interest and investment income
၂.၁၄ သန်း
၁.၂၁ သန်း
၁.၃၇ သန်း
၁.၉၇ သန်း
Interest expense
-
-၁.၀၇ သန်း
-၁.၀၆ သန်း
-၁.၀၈ သန်း
Net interest expenses
၂.၁၄ သန်း
၁.၃၄ သိန်း
၃.၀၇ သိန်း
၈.၉၀ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၃၂ ကုဋေ
-၂.၄၅ ကုဋေ
-၁.၉၅ ကုဋေ
-၂.၃၉ ကုဋေ
Gain or loss from assets sale
၃.၄၀ သောင်း
-
၁.၁၁ သိန်း
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ